| Myelodysplastic Syndrome with Excess Blasts studied in …STUDIED_INderived76 of 76show fewer |
|---|
| → studied in | NCT06484062Phase 1 · recruiting Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839771Phase 3 · active not recruiting A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530034Phase 1 · active not recruiting Hu8F4 in Treating Patients With Advanced Hematologic Malignancies · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816319Phase 1 · active not recruiting TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522976Phase 2 · active not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03383575Phase 2 · recruiting Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600894Phase 2 · active not recruiting Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392353Phase 1/Phase 2 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07719348Phase 1/Phase 2 · not yet recruiting A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399773Phase 2 · active not recruiting Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805605Phase 2 · recruiting Allo HSCT Using RIC and PTCy for Hematological Diseases · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357182Phase 1 · recruiting Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128034Phase 1/Phase 2 · recruiting 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670966Phase 1/Phase 2 · recruiting 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220985Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06372717Phase 1 · recruiting A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05933070Phase 1 · terminated A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01252485recruiting Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06454409Phase 1 · suspended Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214064Phase 2 · not yet recruiting Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05211570Phase 1/Phase 2 · recruiting AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357565Phase 2 · completed Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03850574Phase 1/Phase 2 · recruiting Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05703542Phase 1 · recruiting BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02566304Phase 2 · completed Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03092674Phase 2/Phase 3 · completed Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083170Phase 2 · terminated Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04027309Phase 3 · active not recruiting A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526288Phase 2 · terminated CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858740Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04361058Phase 1 · withdrawn Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540995Phase 1/Phase 2 · terminated Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096782Phase 2 · completed Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589316Phase 1 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119366Phase 2 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756572Phase 2 · completed Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04743115Phase 1 · unknown A Phase I, Open-Label, Dose Escalation and Cohort Expansion Study of BS HH 002.SA in Patients With AML and MDS · condition mapped CURATED_BROADER · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04636918Phase 4 · unknown Ikervis for DED Due to GVHD Post Allo-HSCT · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03338348Phase 2 · completed Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2 · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01241500Phase 3 · completed Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01928537Phase 3 · completed Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01300572Phase 1 · completed Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008177Phase 1 · completed Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175785Phase 2 · completed Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01165996Phase 1/Phase 2 · completed Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872819NA · completed Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831232NA · completed Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01101880Phase 2 · completed Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00988715Phase 1 · completed Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462605Phase 2 · completed MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01607645Phase 2 · terminated Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052520Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01146210completed Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343798Phase 1 · completed A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104962Phase 1 · completed Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096122Phase 1/Phase 2 · completed Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005845Phase 1 · completed Tipifarnib in Treating Patients With Myelodysplastic Syndromes · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01463410terminated Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278330Phase 1 · completed Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095797Phase 1 · completed XK469R in Treating Patients With Refractory Hematologic Cancer · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00015990Phase 2 · completed Thalidomide in Treating Patients With Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005064Phase 1 · completed PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005942Phase 1/Phase 2 · completed Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006213Phase 1 · completed BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084916Phase 2 · completed CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087204Phase 1 · completed Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002798Phase 3 · completed Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098826Phase 1 · completed SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004918Phase 1/Phase 2 · completed Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 76 trials mapped (24 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |